A Randomised Controlled Trial of Consent Procedures for the Use of Residual Tissues for Medical Research: Preferences of and Implications for Patients, Research and Clinical Practice.

Autor: S Rebers, E Vermeulen, A P Brandenburg, T J Stoof, B Zupan-Kajcovski, W J W Bos, M J Jonker, C J Bax, W J van Driel, V J Verwaal, M W van den Brekel, J C Grutters, R A Tupker, L Plusjé, R de Bree, J H Schagen van Leeuwen, E G J Vermeulen, R A de Leeuw, R M Brohet, N K Aaronson, F E Van Leeuwen, M K Schmidt

Publikováno v: PLoS ONE, Vol 11, Iss 3, p e0152509 (2016)

BACKGROUND:Despite much debate, there is little evidence on consequences of consent procedures for residual tissue use. Here, we investigated these consequences for the availability of residual tissue for medical research, clinical practice, and pati

Externí odkaz: https://doaj.org/article/4064b89edb524ad9bfc2dc8c7187d3c3

Drug Survival, Safety, and Effectiveness of Biologics in Older Patients with Psoriasis: A Comparison with Younger Patients-A BioCAPTURE Registry Study

Autor: E. L. M. ter Haar, S. E. Thomas, J. M. P. A. van den Reek, M. E. Otero, M. D. Njoo, P. M. Ossenkoppele, E. N. Kop, S. R. P. Dodemont, J. E. M. Körver, A. L. A. Kuijpers, R. J. Lindhout, R. A. Tupker, J. M. Mommers, M. A. M. Berends, M. I. A. Koetsier, M. S. de Bruin-Weller, M. B. Visch, W. P. Arnold, P. P. M. van Lümig, M. M. Kleinpenning, S. F. K. Lubeek, E. M. G. J. de Jong

Publikováno v: Drugs & Aging, 39(9), 715-727. Adis International Ltd
Drugs & Aging, 39, 715-727
Drugs & Aging, 39, 9, pp. 715-727

Contains fulltext : 282870.pdf (Publisher’s version ) (Open Access) BACKGROUND: Psoriasis is a common inflammatory disease in any age group, but also in older patients (≥ 65 years of age). Since older patients are often excluded from clinical tri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cef7cbf16288c7e8041ef65fccf89e3
https://cris.maastrichtuniversity.nl/en/publications/fdce1bae-b731-41fc-9fbf-793605b45917

The Effectiveness Of Antibacterial Therapeutic Clothing Based On Silver Or Chitosan As Compared With Non-Antibacterial Therapeutic Clothing In Patients With Moderate To Severe Atopic Dermatitis (ABC Trial): Study Protocol For A Pragmatic Randomized Controlled Trial

Autor: Karin B. Fieten, Marie-Louise S. Schuttelaar, Bernd Arents, Margreet L.E. Romeijn, Suzanne G.M.A. Pasmans, Aviël Ragamin, Thomas Rustemeyer, Marieke S Jansen, Frank H. J. Schuren, Jill de Wit, Suzanne Polinder, Renske Schappin, R. A. Tupker, Madelon B. Bronner, Marlies de Graaf, Minke M.F. van Mierlo

Background:Atopic dermatitis (AD) is a chronic inflammatory skin disease that affects 10% to 20% of children and between 2% and 15% of the adults in Western Europe. Since 2000 therapeutic clothing or functional textiles based on silver or chitosan as

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::adf9b77bf130312e91b3c3ac6a3ef128
https://doi.org/10.21203/rs.3.rs-448066/v1

Results of a cosmetovigilance survey in The Netherlands

Autor: Derk P. Bruynzeel, Jacqueline G. M. van Engelen, R. A. Tupker, Lianne de Wit-Bos, Joanne G. W. Salverda, Teetske F. van Gorcum, Lia C. M. Kunkeler, Francois C. Bourgeois, Cees de Heer, Ge A. Donker, Pieter Jan Coenraads, Peter J. C. Bragt, Cees J. W. van Ginkel, Thomas Rustemeyer, Remmelt van Dijk, Judith de Graaf, Anna-Marijke Laheij-de Boer, Harma J. Stenveld, Myrna W. Kooi

Publikováno v: Contact Dermatitis, 68(3), 139-148. Wiley-Blackwell
Salverda, J G W, Bragt, P J C, de Wit-Bos, L, Rustemeyer, T, Coenraads, P J, Tupker, R A, Kunkeler, L C M, Laheij-de Boer, A M, Stenveld, H J, van Ginkel, C J W, Kooi, M W, Bourgeois, F C, van Gorcum, T F, van Engelen, J G M, van Dijk, R, de Graaf, J, Donker, G A, de Heer, C & Bruynzeel, D P 2013, ' Results of a cosmetovigilance survey in The Netherlands ', Contact Dermatitis, vol. 68, no. 3, pp. 139-148 . https://doi.org/10.1111/cod.12005
CONTACT DERMATITIS, 68(3), 139-148. Wiley

Background: Cosmetic products contribute considerably to the incidence of contact dermatitis. In response to a resolution of the Council of Europe, the National Institute for Public Health and the Environment (RIVM) in The Netherlands set up a pilot

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43ad2a233a8a607f6935152e070a34e8
https://doi.org/10.1111/cod.12005

A randomised controlled trial of consent procedures for the use of residual tissues for medical research

Autor: B. Zupan-Kajcovski, J. H. Schagen van Leeuwen, A. P. Brandenburg, W.J. van Driel, R. A. Tupker, Marjanka K. Schmidt, M.W.M. van den Brekel, R. de Bree, Eric Vermeulen, F.E. van Leeuwen, Victor J. Verwaal, T. J. Stoof, L. Plusjé, E. Vermeulen, Marcel C.J. Jonker, Richard M. Brohet, Neil K. Aaronson, Susanne Rebers, Caroline J. Bax, R. A. de Leeuw, Jan C. Grutters, W. J. W. Bos

Publikováno v: PLoS ONE
PLoS ONE [E], 11(3). Public Library of Science
Rebers, S, Vermeulen, E, Brandenburg, A P, Stoof, T J, Zupan-Kajcovski, B, Bos, W J W, Jonker, M, Bax, C J, van Driel, W J, Verwaal, V J, van den Brekel, M W M, Grutters, J C, Tupker, R A, Plusje, L, de Bree, R, van Leeuwen, J H S, Vermeulen, E G J, de Leeuw, R A, Brohet, R, Aaronson, N K, Van Leeuwen, F E & Schmidt, M K 2016, ' A Randomised Controlled Trial of Consent Procedures for the Use of Residual Tissues for Medical Research: Preferences of and Implications for Patients, Research and Clinical Practice ', PLoS ONE, vol. 11, no. 3, e0152509 . https://doi.org/10.1371/journal.pone.0152509
PLoS ONE, 11(3):e0152509. Public Library of Science
PLoS ONE, Vol 11, Iss 3, p e0152509 (2016)

BackgroundDespite much debate, there is little evidence on consequences of consent procedures for residual tissue use. Here, we investigated these consequences for the availability of residual tissue for medical research, clinical practice, and patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb524d66d9c5365604f99c800a7d5a85
http://www.scopus.com/inward/record.url?scp=84962713412&partnerID=8YFLogxK